tolbutamide has been researched along with Bone Loss, Osteoclastic in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Haas, WH | 1 |
| Lavine, MH | 1 |
1 review available for tolbutamide and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
"Footnotes" on diabetes, with special reference to calcification of the metatarsal arteries.
Topics: Aged; Bone Resorption; Calcinosis; Diabetes Complications; Diabetic Angiopathies; Diabetic Neuropath | 1969 |
1 other study available for tolbutamide and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Diagnosis and management of the diabetic patient. Report of a case.
Topics: Anesthesia, Intravenous; Blood Cell Count; Bone Resorption; Carbohydrates; Dental Caries Susceptibil | 1967 |